Mail

UK markets close in 3 hours 46 minutes

FTSE 100
8,237.68
+32.57(+0.40%)
FTSE 250
20,462.61
+81.56(+0.40%)
AIM
774.78
-2.72(-0.35%)
GBP/EUR
1.1830
-0.0004(-0.04%)
GBP/USD
1.2691
-0.0031(-0.24%)
Bitcoin GBP
52,186.80
+899.83(+1.75%)

Best UK mortgage deals of the week

Average two-year mortgage deal is now around 6%

Maravai LifeSciences Holdings, Inc. (MAR.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR

Add to watchlist

6.40

-0.05

(-0.78%)

As of 08:05AM CEST. Market open.

Currency in EUR

Valuation measures⁴

Market cap (intra-day)	852.19M
Enterprise value	853.11M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	3.34
Price/book (mrq)	2.24
Enterprise value/revenue	3.34
Enterprise value/EBITDA	1.32

Trading information

Stock price history

Beta (5Y monthly)	0.06
52-week change ³	-47.13%
S&P500 52-week change ³	25.22%
52-week high ³	12.20
52-week low ³	4.20
50-day moving average ³	8.16
200-day moving average ³	6.83

Share statistics

Avg vol (3-month) ³	17
Avg vol (10-day) ³	N/A
Shares outstanding ⁵	132.83M
Implied shares outstanding ⁶	123.67M
Float ⁸	77.5M
% held by insiders ¹	1.45%
% held by institutions ¹	105.90%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	-47.81%
Operating margin (ttm)	-31.28%

Management effectiveness

Return on assets (ttm)	-1.56%
Return on equity (ttm)	-19.03%

Income statement

Revenue (ttm)	274.1M
Revenue per share (ttm)	2.08
Quarterly revenue growth (yoy)	-18.80%
Gross profit (ttm)	N/A
EBITDA	-3.91M
Net income avi to common (ttm)	-131.04M
Diluted EPS (ttm)	-0.92
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	561.69M
Total cash per share (mrq)	4.23
Total debt (mrq)	618.72M
Total debt/equity (mrq)	79.59%
Current ratio (mrq)	11.32
Book value per share (mrq)	3.10

Cash flow statement

Operating cash flow (ttm)	32.68M
Levered free cash flow (ttm)	-60.97M